Moderator(s):
William F. Fearon, Byeong-Keuk Kim
Panelist(s): Junya Ako, Dominick J. Angiolillo, Jang-Whan Bae, Ho Lam, Kambis Mashayekhi, Nicolas Van Mieghem
Panelist(s): Junya Ako, Dominick J. Angiolillo, Jang-Whan Bae, Ho Lam, Kambis Mashayekhi, Nicolas Van Mieghem
- TAILORED-CHIP Trial: Temporal Dynamic Antiplatelet Strategy for Complex High-Risk PCI
Hanbit Park - ENAVO-TAVR Trial: SGLT-2 Inhibitor for Post-TAVR
Jinho Lee - DEFINE-DM Trial: Imaging- and Physiology-guided State-of-the Art PCI vs. CABG for DM and Multi-Vessel Disease
Hoyun Kim - FATE-MAIN Trial: FFR- vs. Angiography-guided Left Main PCI
Jung-Min Ahn - Panel Discussion l
- EPIC-CAD Trial: Long-Term Antithrombotic Strategy in AF Patients With Stable CAD
Gi-Byoung Nam - PROTECT-HBR Trial: New GI Protection Drug for High-Bleeding Risk Patients Requiring Antithrombotic Agents - P-CAB vs. PPI
Jinho Lee - ASSURE-DES Trial: Optimal Antiplatelet Strategy in DES Patients During Noncardiac Surgery
Hanbit Park - VARIANT-ICD Trial: ICD vs. Medical Therapy Alone in Variant Angina With Aborted SCD
Jung-Min Ahn - Panel Discussion ll